Research Briefing | Apr 7, 2021

Global | Coronavirus Watch: When is the vaccine tipping point?

Despite increasing numbers of new coronavirus cases globally, the possibility that more economies will enjoy both limited domestic restrictions and sustained low new case numbers is growing closer thanks to ongoing vaccination rollouts.

Indeed, the persistent decline in the number of new cases in Israel, even after the reopening of the economy in early March, implies the country has already reached the tipping point allowing fewer restrictions while maintaining lower case numbers. However, it is difficult to tell with certainty exactly when the corner was turned, and the level of immunity needed within the domestic population.

Although the UK is rapidly rolling out vaccines and is experiencing a persistent drop in case numbers, it remains unclear whether mass vaccination or persistent restrictions are leading the improving health situation. Meanwhile, the US and Chile have vaccinated a significant share of their populations but are still recording rising case numbers.

It is uncertain whether any economies other than Israel have reached the tipping point where restrictions can be eased while keeping case numbers low.

Back to Resource Hub

Related Services

Post

UK: Key themes 2026 – Sluggish growth and fiscal worries

We think 2026 will be another challenging year for the UK economy – our GDP growth forecast of 1% is at the bottom of the consensus. Four themes will be key to the outlook, in our view.

Find Out More

Post

Nordics: Key themes 2026 – Bright spots emerging

We forecast growth across the Nordic economies to diverge somewhat next year but share the same underlying drivers.

Find Out More
[autopilot_shortcode]